GlassScriptPhysician profile
Emma Latimore
NPI 1952993503
$6,903.97
in general payments reported to CMS, 2019-2025
38 companies · $1,620 in 2025
The $1,620 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $700 · 2022: $1,016 · 2023: $2,405 · 2024: $1,162 · 2025: $1,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,142 · Travel and Lodging: $1,003 · Education: $43.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,141.67 |
| Travel and Lodging | $1,002.79 |
| Education | $43.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,168.45 | 2021-2025 | Interstim |
| Sumitomo Pharma America, INC. | $620.24 | 2023-2025 | Gemtesa |
| Janssen Biotech, INC. | $530.09 | 2021-2023 | Erleada |
| Urovant Sciences INC | $407.30 | 2021-2022 | |
| Endo USA, INC. | $376.88 | 2024-2025 | Xiaflex, Aveed |
| Pfizer INC. | $338.76 | 2023-2025 | |
| Boston Scientific Corporation | $322.34 | 2024-2025 | Rezum Generator, General - Erectile Dysfunction, Axonics |
| Myovant Sciences INC. | $289.08 | 2021-2022 | |
| Urogen Pharma, INC. | $275.22 | 2023-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $273.27 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $263.53 | 2023-2025 | Provenge |
| C. R. Bard, INC. & Subsidiaries | $237.56 | 2023-2024 | Bard Urinary Drainage Bag |
| Antares Pharma, INC. | $157.11 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Tolmar, INC. | $147.97 | 2023-2025 | Jatenzo, Eligard |
| Tolmar Pharmaceuticals, INC. | $134.82 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $128.25 | 2021-2025 | Barrigel |
| Allergan, INC. | $124.99 | 2022 | |
| Tempus Ai, INC | $120.47 | 2024 | Xt Cdx |
| Astellas Pharma US INC | $114.90 | 2021-2023 | Myrbetriq |
| Endo Pharmaceuticals INC. | $112.04 | 2021-2024 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $93.82 | 2025 | |
| Rochester Medical Corporation | $90.56 | 2021-2022 | |
| 180 Medical, INC. | $80.34 | 2022-2023 | Gentlecath |
| Merck Sharp & Dohme LLC | $72.75 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Blue Earth Diagnostics | $53.45 | 2022-2023 | |
| Abbvie INC. | $43.00 | 2021-2023 | |
| Immunitybio, INC. | $42.51 | 2025 | |
| Myriad Genetic Laboratories, INC. | $39.17 | 2022-2023 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Valencia Technologies Corporation | $33.87 | 2025 | Ecoin Device Kit |
| Calyxo, INC. | $28.32 | 2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $25.48 | 2025 | Adstiladrin |
| Coloplast Corp | $23.77 | 2022 | |
| Olympus America INC. | $23.57 | 2023 | Itind System |
| Palette Life Sciences, INC. | $19.83 | 2023 | |
| Amgen INC. | $19.17 | 2021 | |
| Telix Pharmaceuticals | $18.03 | 2025 | Illuccix |
| Cardinal Health 414 LLC | $18.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Latimore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.